Operaciones Ocugen, Inc. - OCGN CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Condiciones de trading
| Diferencial | 0.05 | ||||||||
|
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.025457% | ||||||||
|
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.003235% | ||||||||
| Horario tarifa nocturna | 21:00 (UTC) | ||||||||
| Cantidad comercializada mínima | 1 | ||||||||
| Divisa | USD | ||||||||
| Margen | 20% | ||||||||
| Mercado de valores | United States of America | ||||||||
| Comisión por operación | 0% |
*Information provided by Capital.com
Ocugen Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Estadísticas clave
| Cierre previo* | 0.43 |
| Abrir* | 0.43 |
| Cambio de 1 año* | -81.47% |
| Rango del día* | 0.43 - 0.43 |
| Rango de 52 semanas | 0.44-3.11 |
| Volumen medio (10 días) | 12.86M |
| Volumen medio (3 meses) | 155.86M |
| Capitalización de mercado | 120.03M |
| Ratio P/E | -100.00K |
| Acciones en circulación | 260.93M |
| Ingresos | N/A |
| EPS | -0.36 |
| Dividendo (Rendimiento %) | N/A |
| Beta | 3.89 |
| Próxima fecha de resultados | Aug 3, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Cierre | Change | Change (%) | Apertura | High | Low |
|---|---|---|---|---|---|---|
| Jun 1, 2023 | 0.43 | 0.00 | 0.00% | 0.43 | 0.43 | 0.43 |
| May 31, 2023 | 0.43 | 0.00 | 0.00% | 0.43 | 0.44 | 0.43 |
| May 30, 2023 | 0.43 | -0.02 | -4.44% | 0.45 | 0.45 | 0.43 |
| May 26, 2023 | 0.44 | 0.01 | 2.33% | 0.43 | 0.44 | 0.42 |
| May 25, 2023 | 0.43 | -0.04 | -8.51% | 0.47 | 0.47 | 0.43 |
| May 24, 2023 | 0.45 | -0.08 | -15.09% | 0.53 | 0.53 | 0.43 |
| May 23, 2023 | 0.69 | -0.01 | -1.43% | 0.70 | 0.75 | 0.69 |
| May 22, 2023 | 0.69 | 0.05 | 7.81% | 0.64 | 0.71 | 0.63 |
| May 19, 2023 | 0.65 | 0.01 | 1.56% | 0.64 | 0.65 | 0.63 |
| May 18, 2023 | 0.63 | -0.04 | -5.97% | 0.67 | 0.67 | 0.61 |
| May 17, 2023 | 0.67 | 0.00 | 0.00% | 0.67 | 0.67 | 0.65 |
| May 16, 2023 | 0.67 | -0.01 | -1.47% | 0.68 | 0.71 | 0.66 |
| May 15, 2023 | 0.71 | 0.06 | 9.23% | 0.65 | 0.72 | 0.65 |
| May 12, 2023 | 0.65 | -0.04 | -5.80% | 0.69 | 0.69 | 0.64 |
| May 11, 2023 | 0.68 | -0.05 | -6.85% | 0.73 | 0.73 | 0.67 |
| May 10, 2023 | 0.72 | 0.01 | 1.41% | 0.71 | 0.74 | 0.70 |
| May 9, 2023 | 0.70 | 0.00 | 0.00% | 0.70 | 0.71 | 0.67 |
| May 8, 2023 | 0.70 | 0.00 | 0.00% | 0.70 | 0.72 | 0.68 |
| May 5, 2023 | 0.67 | -0.02 | -2.90% | 0.69 | 0.69 | 0.66 |
| May 4, 2023 | 0.67 | -0.01 | -1.47% | 0.68 | 0.69 | 0.65 |
Ocugen, Inc. Events
| Hora (UTC) (UTC) | País | Evento |
|---|---|---|
| Monday, June 5, 2023 | ||
| Hora (UTC) (UTC) 20:30 | País US
| Evento Ocugen Inc at Biotechnology Industry Organization (BIO) International Convention Ocugen Inc at Biotechnology Industry Organization (BIO) International ConventionForecast -Previous - |
| Wednesday, June 7, 2023 | ||
| Hora (UTC) (UTC) 12:00 | País US
| Evento Ocugen Inc Annual Shareholders Meeting Ocugen Inc Annual Shareholders MeetingForecast -Previous - |
| Friday, June 9, 2023 | ||
| Hora (UTC) (UTC) 12:00 | País US
| Evento Ocugen Inc Annual Shareholders Meeting Ocugen Inc Annual Shareholders MeetingForecast -Previous - |
| Thursday, August 3, 2023 | ||
| Hora (UTC) (UTC) 12:30 | País US
| Evento Q2 2023 Ocugen Inc Earnings Release Q2 2023 Ocugen Inc Earnings ReleaseForecast -Previous - |
| Monday, November 6, 2023 | ||
| Hora (UTC) (UTC) 13:30 | País US
| Evento Q3 2023 Ocugen Inc Earnings Release Q3 2023 Ocugen Inc Earnings ReleaseForecast -Previous - |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos totales | 0 | 0 | 0.04262 | 0 | 0 |
| Ingresos | 0 | 0.04262 | 0 | ||
| Gastos totales de explotación | 84.868 | 57.628 | 21.3273 | 14.5038 | 28.568 |
| Gastos de venta/general/administración Gastos, total | 35.111 | 22.92 | 7.97405 | 6.0771 | 10.204 |
| Investigación y desarrollo | 49.757 | 35.108 | 13.3533 | 8.08552 | 15.634 |
| Gastos (ingresos) extraordinarios | -0.4 | 0 | 0.34114 | 2.73 | |
| Ingresos de explotación | -84.868 | -57.628 | -21.2847 | -14.5038 | -28.568 |
| Ingresos por intereses (gastos), netos No operativos | -0.079 | -0.71989 | -4.95401 | 20.031 | |
| Otros, netos | 3.517 | -0.71 | 0.18266 | -0.78487 | -0.106 |
| Ingresos netos antes de impuestos | -81.351 | -58.417 | -21.822 | -20.2426 | -8.643 |
| Ingresos netos después de impuestos | -81.351 | -58.365 | -21.822 | -20.2426 | -8.643 |
| Beneficio neto antes de partidas extra. Elementos | -81.351 | -58.365 | -21.822 | -20.2426 | -8.643 |
| Ingresos netos | -81.351 | -58.365 | -21.822 | -20.2426 | -8.643 |
| Total Adjustments to Net Income | 0 | -12.5463 | 0.121 | ||
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -81.351 | -58.365 | -34.3683 | -20.2426 | -8.522 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -81.351 | -58.365 | -34.3683 | -20.2426 | -8.522 |
| Beneficio neto diluido | -81.351 | -58.365 | -34.3683 | -20.2426 | -8.522 |
| Promedio ponderado de acciones diluidas | 214.6 | 195.013 | 112.236 | 13.8938 | 0.60676 |
| BPA diluido sin partidas extraordinarias | -0.37908 | -0.29929 | -0.30621 | -1.45695 | -14.045 |
| Dividends per Share - Common Stock Primary Issue | |||||
| BPA normalizado diluido | -0.37908 | -0.30062 | -0.30621 | -1.4324 | -9.54575 |
| Total de partidas extraordinarias | 0 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Ingresos totales | 0 | 0 | 0 | 0 | 0 |
| Gastos totales de explotación | 17.751 | 24.15 | 23.119 | 19.565 | 18.034 |
| Gastos de venta/general/administración Gastos, total | 8.193 | 6.937 | 7.497 | 10.558 | 10.119 |
| Investigación y desarrollo | 9.558 | 17.213 | 15.622 | 9.007 | 7.915 |
| Ingresos de explotación | -17.751 | -24.15 | -23.119 | -19.565 | -18.034 |
| Ingresos por intereses (gastos), netos No operativos | |||||
| Ingresos netos antes de impuestos | -16.498 | -21.939 | -21.922 | -19.471 | -18.019 |
| Ingresos netos después de impuestos | -16.498 | -21.939 | -21.922 | -19.471 | -18.019 |
| Beneficio neto antes de partidas extra. Elementos | -16.498 | -21.939 | -21.922 | -19.471 | -18.019 |
| Ingresos netos | -16.498 | -21.939 | -21.922 | -19.471 | -18.019 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -16.499 | -21.939 | -21.922 | -19.471 | -18.019 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -16.499 | -21.939 | -21.922 | -19.471 | -18.019 |
| Beneficio neto diluido | -16.499 | -21.939 | -21.922 | -19.471 | -18.019 |
| Promedio ponderado de acciones diluidas | 225.524 | 220.133 | 216.591 | 215.863 | 205.693 |
| BPA diluido sin partidas extraordinarias | -0.07316 | -0.09966 | -0.10121 | -0.0902 | -0.0876 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| BPA normalizado diluido | -0.07316 | -0.09966 | -0.10121 | -0.0902 | -0.0876 |
| Ingresos | |||||
| Otros, netos | 1.253 | 2.211 | 1.197 | 0.094 | 0.015 |
| Total Adjustments to Net Income | -0.001 | ||||
| Gastos (ingresos) extraordinarios |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 98.492 | 102.646 | 25.8777 | 15.7662 | 16.4 |
| Efectivo e inversiones a corto plazo | 90.934 | 94.958 | 24.0393 | 7.44405 | 15.542 |
| Efectivo y Equivalentes | 77.563 | 94.958 | 24.0393 | 7.44405 | 15.542 |
| Prepaid Expenses | 7.558 | 2.7 | 1.83836 | 1.32217 | 0.686 |
| Total Assets | 108.632 | 105.761 | 27.3764 | 16.8074 | 17.428 |
| Property/Plant/Equipment, Total - Net | 9.963 | 2.751 | 1.06662 | 0.22246 | 0.141 |
| Intangibles, Net | |||||
| Other Long Term Assets, Total | 0.177 | 0.364 | 0.43205 | 0.81876 | 0.887 |
| Total Current Liabilities | 18.46 | 7 | 3.61355 | 4.54396 | 2.873 |
| Accounts Payable | 8.062 | 2.312 | 0.39503 | 1.89561 | 1.59 |
| Accrued Expenses | 10.398 | 4.688 | 2.97464 | 2.44236 | 1 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | 0.23412 | 0 | 0 | |
| Other Current Liabilities, Total | 0.00976 | 0.20599 | 0.283 | ||
| Total Liabilities | 24.58 | 9.943 | 5.82591 | 5.78904 | 17.886 |
| Total Long Term Debt | 2.289 | 1.712 | 1.82304 | 1.07212 | 0 |
| Long Term Debt | 2.289 | 1.712 | 1.82304 | 1.07212 | |
| Other Liabilities, Total | 3.831 | 1.231 | 0.38932 | 0.17295 | 15.013 |
| Total Equity | 84.052 | 95.818 | 21.5504 | 11.0184 | -0.458 |
| Common Stock | 2.217 | 1.995 | 1.84133 | 0.52747 | 0.513 |
| Additional Paid-In Capital | 294.874 | 225.537 | 93.0587 | 62.0186 | 215.859 |
| Retained Earnings (Accumulated Deficit) | -213.018 | -131.667 | -73.3018 | -51.4798 | -216.83 |
| Total Liabilities & Shareholders’ Equity | 108.632 | 105.761 | 27.3764 | 16.8074 | 17.428 |
| Total Common Shares Outstanding | 221.6 | 199.381 | 184.012 | 52.6252 | 1.03376 |
| Inversiones a corto plazo | 13.371 | 0 | |||
| Redeemable Preferred Stock | 0.001 | 0.001 | 0 | 0 | |
| Other Equity, Total | 0.026 | 0 | |||
| Other Current Assets, Total | 4.988 | 0 | 7 | 0.172 | |
| Property/Plant/Equipment, Total - Gross | 10.584 | 3.125 | 1.29231 | 10.427 | |
| Accumulated Depreciation, Total | -0.621 | -0.374 | -0.2257 | -10.286 | |
| Treasury Stock - Common | -0.048 | -0.048 | -0.04786 | -0.04786 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 84.401 | 98.492 | 107.497 | 122.569 | 138.027 |
| Efectivo e inversiones a corto plazo | 76.721 | 90.934 | 101.602 | 115.005 | 129.771 |
| Efectivo y Equivalentes | 68.259 | 77.563 | 101.602 | 115.005 | 129.771 |
| Prepaid Expenses | 7.68 | 7.558 | 5.895 | 7.564 | 8.256 |
| Other Current Assets, Total | |||||
| Total Assets | 96.299 | 108.632 | 116.239 | 130.088 | 141.727 |
| Property/Plant/Equipment, Total - Net | 7.952 | 9.963 | 8.557 | 7.325 | 3.345 |
| Property/Plant/Equipment, Total - Gross | 8.739 | 10.584 | 9.135 | 7.847 | 3.786 |
| Accumulated Depreciation, Total | -0.787 | -0.621 | -0.578 | -0.522 | -0.441 |
| Other Long Term Assets, Total | 3.946 | 0.177 | 0.185 | 0.194 | 0.355 |
| Total Current Liabilities | 15.683 | 18.46 | 14.907 | 10.338 | 7.687 |
| Accounts Payable | 8.092 | 8.062 | 6.46 | 5.921 | 3.896 |
| Accrued Expenses | 6.335 | 10.398 | 8.447 | 4.417 | 3.791 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 1.256 | ||||
| Total Liabilities | 20.499 | 24.58 | 20.936 | 15.98 | 10.598 |
| Total Long Term Debt | 1.058 | 2.289 | 2.265 | 1.75 | 1.731 |
| Long Term Debt | 1.058 | 2.289 | 2.265 | 1.75 | 1.731 |
| Other Liabilities, Total | 3.758 | 3.831 | 3.764 | 3.892 | 1.18 |
| Total Equity | 75.8 | 84.052 | 95.303 | 114.108 | 131.129 |
| Common Stock | 2.265 | 2.217 | 2.168 | 2.163 | 2.158 |
| Additional Paid-In Capital | 303.073 | 294.874 | 284.231 | 281.139 | 278.704 |
| Retained Earnings (Accumulated Deficit) | -229.516 | -213.018 | -191.079 | -169.157 | -149.686 |
| Treasury Stock - Common | -0.048 | -0.048 | -0.048 | -0.048 | -0.048 |
| Other Equity, Total | 0.025 | 0.026 | 0.03 | 0.01 | |
| Total Liabilities & Shareholders’ Equity | 96.299 | 108.632 | 116.239 | 130.088 | 141.727 |
| Total Common Shares Outstanding | 226.427 | 221.6 | 216.688 | 216.15 | 215.631 |
| Redeemable Preferred Stock | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
| Inversiones a corto plazo | 8.462 | 13.371 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos netos/Línea de salida | -81.351 | -58.365 | -21.822 | -20.2426 | -8.643 |
| Efectivo de actividades de explotación | -60.079 | -47.941 | -14.7087 | -16.8933 | -15.777 |
| Efectivo de actividades de explotación | 0.48 | 0.229 | 0.10211 | 0.06061 | 0.45 |
| Partidas no monetarias | 11.597 | 7.757 | 8.2213 | 6.40129 | -14.779 |
| Cash Taxes Paid | 0 | 0.052 | 0.105 | ||
| Intereses pagados en efectivo | 0.001 | ||||
| Cambios en el capital circulante | 9.195 | 2.438 | -1.21018 | -3.11255 | 7.195 |
| Efectivo de actividades de inversión | -16.967 | -1.816 | -0.30683 | -2.35672 | -1.113 |
| Gastos de capital | -4.457 | -1.066 | -0.30683 | -0.02945 | -2.013 |
| Efectivo procedente de actividades de financiación | 59.475 | 120.676 | 31.611 | 25.0665 | 25.351 |
| Elementos de flujo de caja de financiación | -0.592 | -8.525 | -1.48355 | -0.17293 | -0.178 |
| Emisión (retiro) de acciones, neto | 59.567 | 129.211 | 37.822 | 23.7294 | 25.529 |
| Variación neta de la tesorería | -17.546 | 70.919 | 16.5955 | 5.81646 | 8.461 |
| Otras partidas de flujo de caja de inversión, total | -12.51 | -0.75 | 0 | -2.32727 | 0.9 |
| Emisión (amortización) de deuda, neta | 0.5 | -0.01 | -4.72744 | 1.51 | |
| Efectos del cambio de divisas | 0.025 | 0 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -16.498 | -81.351 | -59.412 | -37.49 | -18.019 |
| Cash From Operating Activities | -18.24 | -60.079 | -43.165 | -28.863 | -15.066 |
| Cash From Operating Activities | 0.174 | 0.48 | 0.307 | 0.166 | 0.076 |
| Non-Cash Items | 3.053 | 11.597 | 7.721 | 5.75 | 3.497 |
| Changes in Working Capital | -4.969 | 9.195 | 8.219 | 2.711 | -0.62 |
| Cash From Investing Activities | 3.441 | -16.967 | -1.672 | -1.589 | -0.223 |
| Capital Expenditures | -1.612 | -4.457 | -2.433 | -1.589 | -0.223 |
| Cash From Financing Activities | 5.496 | 59.475 | 51.3 | 50.338 | 50.102 |
| Financing Cash Flow Items | -0.235 | -0.592 | -0.398 | -0.248 | -0.075 |
| Issuance (Retirement) of Stock, Net | 5.731 | 59.567 | 51.198 | 50.586 | 50.177 |
| Issuance (Retirement) of Debt, Net | 0.5 | 0.5 | 0 | 0 | |
| Net Change in Cash | -9.304 | -17.546 | 6.493 | 19.896 | 34.813 |
| Other Investing Cash Flow Items, Total | 5.053 | -12.51 | 0.761 | 0 | |
| Cash Taxes Paid | 0 | 0 | |||
| Foreign Exchange Effects | -0.001 | 0.025 | 0.03 | 0.01 |
| Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
|---|---|---|---|---|---|---|
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.359 | 13983184 | 325773 | 2023-03-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.9879 | 13014850 | 1186595 | 2023-03-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.3269 | 6071506 | -42605 | 2023-04-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7864 | 4661333 | 517806 | 2023-03-31 | LOW |
| JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 1.1401 | 2974934 | -38269 | 2023-03-31 | LOW |
| Susquehanna International Group, LLP | Investment Advisor | 0.9278 | 2420929 | 1982473 | 2023-03-31 | MED |
| Renaissance Technologies LLC | Hedge Fund | 0.8744 | 2281548 | 858692 | 2023-03-31 | HIGH |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.6232 | 1626024 | -54370 | 2023-03-31 | LOW |
| Charles Schwab Investment Management, Inc. | Investment Advisor | 0.5821 | 1518828 | -101478 | 2023-03-31 | LOW |
| Ergoteles Capital | Hedge Fund | 0.5813 | 1516801 | 1516801 | 2023-03-31 | HIGH |
| Millennium Management LLC | Hedge Fund | 0.4858 | 1267682 | 1267682 | 2023-03-31 | HIGH |
| KVM Holdings, L.L.C. | Corporation | 0.4389 | 1145299 | 0 | 2023-04-13 | |
| HRT Financial LP | Investment Advisor | 0.3862 | 1007728 | 1007728 | 2023-03-31 | LOW |
| Zhang (Junge) | Individual Investor | 0.3698 | 964904 | 0 | 2023-04-13 | |
| BNY Mellon Asset Management | Investment Advisor | 0.3315 | 865067 | 25820 | 2023-03-31 | LOW |
| Kompella (Uday B.) | Individual Investor | 0.2702 | 705090 | 0 | 2023-04-13 | |
| Nuveen LLC | Pension Fund | 0.2576 | 672249 | -483391 | 2023-03-31 | LOW |
| BlackRock Investment Management, LLC | Investment Advisor/Hedge Fund | 0.23 | 600261 | 15607 | 2023-03-31 | LOW |
| Goldman Sachs & Company, Inc. | Research Firm | 0.1887 | 492420 | -900714 | 2023-03-31 | MED |
| BofA Global Research (US) | Research Firm | 0.1878 | 490023 | -2389134 | 2023-03-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group535K+
Traders
87K+
Clientes activos mensualmente
$113M+
Volumen mensual de inversión
$64M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
Comisión de la operación
0
- 1:1
Apalancamiento
1:1
- 20
- 100
- 500
- 1000
- 10000
Inversión
Tamaño de la operación (Apalancamiento x Inversión)
Apertura
Cierre
En corto En largo
Ocugen, Inc. Company profile
Sobre Ocugen Inc
Ocugen, Inc. es una empresa biofarmacéutica centrada en el desarrollo de terapias génicas para curar enfermedades de ceguera y en el desarrollo de una vacuna para la COVID-19. La cartera de productos tecnológicos de la empresa incluye: Vacuna COVID-19 (0,5), Plataforma de Terapia Génica Modificadora y Nuevas Terapias Biológicas para Enfermedades de la Retina. El candidato a la vacuna COVID-19 se centra en el desarrollo, la fabricación y la comercialización de COVAXIN para la prevención de la COVID-19 en humanos en el territorio de Ocugen Covaxin. COVAXIN es un candidato a vacuna contra la COVID-19 inactivada y formulada con el virus inactivado del SARS-CoV-2. La plataforma de Terapia Génica Modificadora está diseñada para enfermedades de la retina, como la retinosis pigmentaria (RP), la amaurosis congénita leberina (LCA) y la degeneración macular seca asociada a la edad (DMS). Está desarrollando el OCU200, un producto biológico candidato para tratar el edema macular diabético (EMD), la retinopatía diabética (RD) y la DMAE húmeda. OCU400, su primer producto candidato que se está desarrollando con su plataforma de terapia génica modificadora.
El precio actual de la acción Ocugen, Inc. en tiempo real es 0.43 USD. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: Revance The, Fathom Digital Manufacturing Corporation, Beam Therapeutics Inc., Broadcom Inc., Gazit Globe Ltd y MicroSectors U.S. Big Banks Index -3X Inverse Leveraged ETNs. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
| Industry: | Biotechnology & Medical Research (NEC) |
11 Great Valley Parkway
MALVERN
PENNSYLVANIA 19355
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 535.000 traders de todo el mundo que eligen operar con Capital.com